Recent Quarter Total Invested
$2.67 B
Recent Quarter Institutional Ownership Percentage
96.82%
Total Invested of Last Quarter
$2.98 B
Ownership Percentage of Last Quarter
94.71%
MoonLake Immunotherapeutics Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 08/14/2024 | 21.75 M | $956.40 M | 0.00% | 34.73% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 8.49 M | $373.49 M | 0.00% | 13.56% |
| FMR LLC | 08/13/2024 | 3.64 M | $160.23 M | -16.63% | 5.82% |
| AVORO CAPITAL ADVISORS LLC | 08/14/2024 | 2.77 M | $121.80 M | 7.36% | 4.42% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 2.56 M | $112.63 M | 19.93% | 4.09% |
| CITADEL ADVISORS LLC | 08/14/2024 | 2.27 M | $99.62 M | -1.89% | 3.62% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 1.83 M | $80.25 M | -20.13% | 2.91% |
| HOLOCENE ADVISORS, LP | 08/14/2024 | 1.63 M | $71.51 M | 11.79% | 2.60% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 1.25 M | $55.04 M | 691.44% | 2.00% |
| FEDERATED HERMES, INC. | 08/08/2024 | 1.13 M | $49.62 M | 2.61% | 1.80% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 08/14/2024 | 1.12 M | $49.14 M | 22.70% | 1.78% |
| MARSHALL WACE, LLP | 08/14/2024 | 1.10 M | $48.31 M | 115.02% | 1.75% |
| ALLIANCEBERNSTEIN L.P. | 08/14/2024 | 1.02 M | $44.93 M | 6.93% | 1.63% |
| LOGOS GLOBAL MANAGEMENT LP | 08/27/2024 | 750,000 | $32.98 M | 100.00% | 1.20% |
| POLAR CAPITAL HOLDINGS PLC | 08/14/2024 | 678,169 | $29.82 M | -20.96% | 1.08% |
| FRED ALGER MANAGEMENT, LLC | 08/14/2024 | 659,029 | $28.98 M | -1.15% | 1.05% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2024 | 584,263 | $25.69 M | 37.57% | 0.93% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 521,713 | $22.94 M | 166.36% | 0.83% |
| BLACKROCK INC. | 08/13/2024 | 392,024 | $17.24 M | -3.98% | 0.63% |
| FINEPOINT CAPITAL LP | 08/13/2024 | 388,835 | $17.10 M | 7.74% | 0.62% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 372,657 | $16.39 M | 34.81% | 0.59% |
| CAMBER CAPITAL MANAGEMENT LP | 08/14/2024 | 355,000 | $15.61 M | 100.00% | 0.57% |
| PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 345,840 | $15.21 M | -30.81% | 0.55% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 343,235 | $15.09 M | 15.94% | 0.55% |
| GHOST TREE CAPITAL, LLC | 08/14/2024 | 300,000 | $13.19 M | 0.00% | 0.48% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 283,649 | $12.47 M | 31.43% | 0.45% |
| 5AM VENTURE MANAGEMENT, LLC | 08/14/2024 | 282,313 | $12.41 M | 0.00% | 0.45% |
| CANDRIAM S.C.A. | 08/05/2024 | 239,000 | $10.51 M | 0.00% | 0.38% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 07/19/2024 | 228,803 | $10.06 M | -0.19% | 0.37% |
| WOODLINE PARTNERS LP | 08/14/2024 | 226,717 | $9.97 M | 9.31% | 0.36% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 08/14/2024 | 220,000 | $9.67 M | 0.00% | 0.35% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 216,964 | $9.54 M | 934.39% | 0.35% |
| TD ASSET MANAGEMENT INC | 08/02/2024 | 209,234 | $9.20 M | 2.52% | 0.33% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 08/08/2024 | 203,737 | $8.96 M | -2.74% | 0.33% |
| VICTORY CAPITAL MANAGEMENT INC | 08/05/2024 | 174,682 | $7.68 M | 15.96% | 0.28% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2024 | 125,000 | $5.50 M | 100.00% | 0.20% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 116,438 | $5.12 M | -18.83% | 0.19% |
| ALTIUM CAPITAL MANAGEMENT LP | 08/15/2024 | 115,000 | $5.06 M | 100.00% | 0.18% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 08/14/2024 | 114,234 | $5.02 M | 37.91% | 0.18% |
| AXA S.A. | 08/14/2024 | 104,314 | $4.59 M | 0.06% | 0.17% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2024 | 101,224 | $4.45 M | 0.15% | 0.16% |
| VANGUARD GROUP INC | 08/13/2024 | 91,840 | $4.04 M | -0.50% | 0.15% |
| WALLEYE CAPITAL LLC | 08/14/2024 | 86,278 | $3.79 M | -36.76% | 0.14% |
| EVERSEPT PARTNERS, LP | 08/14/2024 | 71,596 | $3.15 M | 100.00% | 0.11% |
| MORGAN STANLEY | 08/14/2024 | 69,027 | $3.04 M | -69.88% | 0.11% |
| TWINBEECH CAPITAL LP | 08/14/2024 | 58,552 | $2.57 M | 100.00% | 0.09% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 58,500 | $2.57 M | 8.28% | 0.09% |
| VOYA INVESTMENT MANAGEMENT LLC | 08/14/2024 | 58,245 | $2.56 M | -8.61% | 0.09% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 54,036 | $2.38 M | 159.05% | 0.09% |
| ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 53,187 | $2.34 M | 0.00% | 0.08% |
MoonLake Immunotherapeuticsinstitutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of MLTX shares?
During the previous two years, 137 institutional investors and hedge funds held shares of MoonLake Immunotherapeutics. The most heavily invested institutionals were:
BVF INC/IL: 21.75 M
Cormorant Asset Management, LP: 8.49 M
FMR LLC: 3.64 M
Avoro Capital Advisors LLC: 2.77 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.56 M
CITADEL ADVISORS LLC: 2.27 M
-
What percentage of MoonLake Immunotherapeutics stock is owned by institutional investors?
96.82% of MoonLake Immunotherapeutics stock is owned by institutional investors.
-
How much institutional buying is happening at MLTX ?
Institutional investors have bought a total of 61.71 M shares in the last 24 months. This purchase volume represents approximately $3.43 B in transactions.